15 results
10-Q
2021 Q2
CADL
Candel Therapeutics Inc
8 Sep 21
Quarterly report
8:37am
, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare, review the relationship between pricing and manufacturer … disclosure and transparency measures, and, in some cases, designed to encourage importation from other countries and bulk purchasing. In addition, regional
S-1
CADL
Candel Therapeutics Inc
25 Jun 21
IPO registration
5:28pm
and state legislation designed to, among other things, bring more transparency to drug pricing, reduce the cost of prescription drugs under Medicare … , restrictions on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from
DRS/A
CADL
Candel Therapeutics Inc
31 Mar 21
Draft registration statement (amended)
12:00am
. Congressional inquiries and proposed federal and state legislation designed to, among other things, bring more transparency to drug pricing, reduce … on certain product access and marketing cost disclosure and transparency measures, and, in some cases, designed to encourage importation from other
S-1/A
q5t8jy30ye
16 Jul 21
IPO registration (amended)
6:07am
424B4
3k1wx0q4b gflxqpey9
28 Jul 21
Prospectus supplement with pricing info
4:02pm
10-K
8hbxysucaos
29 Mar 22
Annual report
8:46am
- Prev
- 1
- Next